Current Status, Barriers, and Future Directions for Humanized Mouse Models to Evaluate Stem Cell-Based Islet Cell...

Area of Science:

• Regenerative Medicine
• Immunology
• Endocrinology

Background:

• Islet cell transplantation (ITx) shows improved long-term graft survival and glycemic control but faces challenges with immunosuppression and donor availability.
• Stem cell-derived functional islet-like clusters present a renewable alternative, potentially reducing or eliminating the need for immunosuppression.

Purpose of the Study:

• To synthesize current stem cell-derived ITx approaches.
• To review the utility of humanized mice models in evaluating these therapies.
• To explore the potential of humanized mice models for bridging the gap between preclinical rodent studies and human clinical trials for stem cell-based ITx.

Main Methods:

• Review of current stem cell-derived ITx strategies.
• Analysis of humanized mice models for assessing allogeneic and autologous inducible pluripotent stem cell (iPSC)-based ITx.
• Identification of immunologic questions and future research directions.

Main Results:

• Stem cell-derived therapies offer a promising, potentially immunosuppression-free solution for type 1 diabetes treatment.
• Humanized mice models are valuable tools for evaluating the efficacy and safety of stem cell-based ITx.
• Further research is needed to address unique immunologic challenges associated with stem cell-based ITx.

Conclusions:

• Stem cell-derived islet-like clusters hold significant promise for a functional cure for type 1 diabetes.
• Humanized mice models are essential for advancing stem cell-based ITx from preclinical research to human clinical trials.
• Addressing immunologic considerations in humanized mice models is critical for the successful translation of these therapies.